Germany Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Germany Respiratory Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Germany Respiratory Devices Market is expected to register a CAGR of 5.5% during the forecast period. This is attributing to the increasing prevalence of respiratory disorders, such as COPD, TB, Asthma, and Sleep Apnea, technological advancements, and large patient population. As per the National Institute of Health Research 2019, the prevalence of Chronic obstructive pulmonary disease (COPD) in Germany is around 2.7 million. In addition, according to the Global Health Data Exchange, in 2017 approximately 575,558 people are affected by COPD in Germany. Thus, the presence of such a large number will demand respiratory devices and drive the market in Germany. Moreover, the incidence of Asthma population has been increased from past years. As per the Global Health Data Exchange in 2016 the number of new cases reported in Germany was 202,652.32 which further increased to 202,839.14 in 2017 and this is expected to rise in the future also.

Furthermore, Increasing R&D expenditure by innovators and generic players, technological advancements associated with respiratory devices, and rising ageing population will also fuel the Germany respiratory devices Market. However, high costs associated with the devices may hamper the market to a certain extent.

Key Market TrendsTherapeutic devices in Germany Respiratory Device is Estimated to Witness a Healthy Growth in Future.

Therapeutic devices are estimated to witness healthy growth in the future attributed to the growing prevalence of respiratory disorders, rising chronic diseases, and growing geriatric population. Therapeutic devices comprise of CPAP Devices, BiPAP Devices, Humidifiers, Nebulizers, Ventilators, Oxygen Concentrators, and Inhalers. These are essential in the healing of the respiratory disorder population.

The CPAP and BiPAP devices are widely used in obstructive sleep apnea patient population. The rising number of sleep apnea population in Germany and the availability of reimbursement coverage in this region are expected to fuel the therapeutic device segment growth. This rising prevalence and enhanced patient compliance will likely positively impact segment growth.

Competitive Landscape

The Germany Respiratory Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Geratherm Respiratory GmbH, DeVilbiss Healthcare GmbH, Drägerwerk AG, Fisher & Paykel Healthcare Limited., GENERAL ELECTRIC COMPANY, GlaxoSmithKline plc, Invacare Corporation, Chart Industries, Koninklijke Philips NV, and Medtronic.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Companies Mentioned

IBM Corporation
Oracle Corporation
Internap Corporation
Packet Inc. (An Equinix Inc. Company)
Scaleway Inc.
Amazon Web Services Inc
Rackspace Inc.
CenturyLink, Inc.
LightEdge Solutions, Inc

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.